Increased Circulating Levels of SDF-1 (CXCL12) in Type 2 Diabetic Patients Are Correlated to Disease State but Are Unrelated to Polymorphism of the SDF-1β Gene in the Iranian Population

Glycine treatment decreases proinflammatory cytokines and increases interferon-γ in patients with Type 2 diabetes

(2014) M. Cruz et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Assessment of CXCL12 (SDF-1α) Polymorphisms and Its Serum Level in Posttransfusion Occult HBV-infected Patients in Southeastern Iran

(2010) Gholamhossein Hassanshahi et al.   ARCHIVES OF MEDICAL RESEARCH

Prevalence of occult hepatitis B infection in a highly endemic area for chronic hepatitis B: a study of a large blood donor population

(2010) M.-F. Yuen et al.   GUT

Nephropathic complication of type-2 diabetes is following pattern of autoimmune diseases?

(2009) Mohammad Kazemi Arababadi et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Podocytes produce homeostatic chemokine stromal cell-derived factor-1/CXCL12, which contributes to glomerulosclerosis, podocyte loss and albuminuria in a mouse model of type 2 diabetes

(2009) S. G. Sayyed et al.   DIABETOLOGIA

Hypoglycemic pharmacological treatment of type 2 diabetes: Targeting the endothelium

(2008) David Nathanson et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Angiotensin II and the development of insulin resistance: Implications for diabetes

(2008) J. Alberto Olivares-Reyes et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Nutrition interventions for the prevention of type 2 diabetes

(2008) Nelia P. Steyn et al.   PROCEEDINGS OF THE NUTRITION SOCIETY